 | Up a level |
Number of items: 1.
Wolf, J., Groen, H. J. M., Tan, D. S. W., Garon, E. B., Demanse, D., Robeva, A., Yovine, A., Fairchild, L., Boran, A. D. and Heist, R. (2022). Response to capmatinib in patients (pts) with advanced non-small cell lung cancer (NSCLC) and MET exon 14 skipping (METex14) mutation: Whole transcriptome analysis from phase II GEOMETRY Mono-1 study. Ann. Oncol., 33 (7). S. S1003 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041